SELLAS Life Sciences Group (SLS) Earnings Analysis
SELLAS Life Sciences Group (SLS) next reports earnings on 2026-08-11, consensus EPS -0.045 USD. Last quarter (2026-03-19) it beat with EPS -0.05 USD vs -0.06333 USD est (+21%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -52.91.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SLS next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.045 USD |
| Revenue estimate | n/a |
SLS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-19 | -0.05 USD | -0.06333 USD | +21% | Beat |
| 2025-11-12 | -0.06 USD | -0.06333 USD | +5.3% | Beat |
| 2025-03-20 | -0.08 USD | -0.11 USD | +27.3% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
SLS valuation and analyst view
| Trailing P/E | -52.91 |
|---|---|
| Trailing EPS | -0.17078 USD |
| Price / book | 19.40 |
| Dividend yield | 0.00% |
| Market cap | 2.24B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 25 USD |
Related research pages
Frequently asked questions
When is SELLAS Life Sciences Group (SLS)'s next earnings date?
SELLAS Life Sciences Group is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.045 USD.
Did SLS beat earnings last quarter?
In its 2026-03-19 report, SLS posted EPS of -0.05 USD versus a -0.06333 USD estimate — a beat of 21%.
What is SLS's earnings track record?
Over the last 3 reported quarters with consensus data, SLS beat estimates 3 times (100%).
What is SLS's current P/E ratio and EPS?
SLS trades at a trailing P/E of -52.91 on trailing EPS of -0.17078349271009818 USD.
What do analysts rate SLS?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 25 USD.